Coronavirus Update
In response to the current COVID-19 pandemic, Prominex is accelerating its plans for a 5-minute SARS-CoV-2 test on its point-of-care molecular diagnostic platform.
“We are committed to providing greater access to affordable and rapid infectious disease diagnostics for STI and respiratory infections. Our SARS-CoV-2 test can deliver accurate results in 5 minutes aiding healthcare professionals with efficient treatment and infection control decisions.”
-Paul Thomas, CEO